Cosciens Biopharma Stock Performance
| CSCI Stock | 2.16 0.10 4.85% |
On a scale of 0 to 100, COSCIENS Biopharma holds a performance score of 2. The firm shows a Beta (market volatility) of 0.95, which signifies possible diversification benefits within a given portfolio. COSCIENS Biopharma returns are very sensitive to returns on the market. As the market goes up or down, COSCIENS Biopharma is expected to follow. Please check COSCIENS Biopharma's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether COSCIENS Biopharma's price patterns will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in COSCIENS Biopharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, COSCIENS Biopharma demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
Last Split Factor 1:4 | Last Split Date 2024-05-03 |
1 | Real time breakdown of COSCIENS Biopharma Inc. stock performance - Trade Volume Summary Fast Exit and Entry Trade Guides - newser.com | 10/21/2025 |
2 | Strategic Investment Report - news.stocktradersdaily.com | 10/31/2025 |
3 | Will COSCIENS Biopharma Inc. stock see insider buying - Treasury Yields Daily Profit Focused Screening - newser.com | 11/04/2025 |
4 | Chart overlay techniques for tracking COSCIENS Biopharma Inc. - 2025 Market Sentiment Fast Entry High Yield Tips - newser.com | 11/13/2025 |
5 | Can COSCIENS Biopharma Inc. stock deliver surprise earnings beat - 2025 Market Overview Free Accurate Trade Setup Notifications - newser.com | 11/19/2025 |
6 | COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapo... | 12/01/2025 |
7 | Trading Advice - news.stocktradersdaily.com | 12/16/2025 |
8 | United States Hair Care Products Market to Reach 38.27 Billion by 2033 Analysis of Trends, Investment Opportunities and Competition | 12/29/2025 |
| Begin Period Cash Flow | 6.7 M | |
| Total Cashflows From Investing Activities | 25.1 M |
COSCIENS Biopharma Relative Risk vs. Return Landscape
If you would invest 261.00 in COSCIENS Biopharma on October 8, 2025 and sell it today you would lose (45.00) from holding COSCIENS Biopharma or give up 17.24% of portfolio value over 90 days. COSCIENS Biopharma is currently generating 0.3742% in daily expected returns and assumes 12.1954% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than COSCIENS, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
COSCIENS Biopharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for COSCIENS Biopharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as COSCIENS Biopharma, and traders can use it to determine the average amount a COSCIENS Biopharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0307
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CSCI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average COSCIENS Biopharma is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of COSCIENS Biopharma by adding it to a well-diversified portfolio.
COSCIENS Biopharma Fundamentals Growth
COSCIENS Stock prices reflect investors' perceptions of the future prospects and financial health of COSCIENS Biopharma, and COSCIENS Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on COSCIENS Stock performance.
| Return On Equity | -1.13 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (2.00) % | ||||
| Operating Margin | (0.86) % | ||||
| Current Valuation | 1.31 M | ||||
| Shares Outstanding | 3.18 M | ||||
| Price To Book | 1.17 X | ||||
| Price To Sales | 0.92 X | ||||
| Revenue | 13.78 M | ||||
| Gross Profit | 4.42 M | ||||
| EBITDA | (13.49 M) | ||||
| Net Income | (15.31 M) | ||||
| Total Debt | 2.31 M | ||||
| Book Value Per Share | 2.23 X | ||||
| Cash Flow From Operations | (14.57 M) | ||||
| Earnings Per Share | (6.54) X | ||||
| Market Capitalization | 8.64 M | ||||
| Total Asset | 35.07 M | ||||
| Retained Earnings | (12.11 M) | ||||
| Working Capital | 16.76 M | ||||
About COSCIENS Biopharma Performance
By evaluating COSCIENS Biopharma's fundamental ratios, stakeholders can gain valuable insights into COSCIENS Biopharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if COSCIENS Biopharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if COSCIENS Biopharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 161.73 | 200.92 | |
| Return On Tangible Assets | (0.39) | (0.41) | |
| Return On Capital Employed | (0.85) | (0.81) | |
| Return On Assets | (0.39) | (0.41) | |
| Return On Equity | (1.34) | (1.40) |
Things to note about COSCIENS Biopharma performance evaluation
Checking the ongoing alerts about COSCIENS Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for COSCIENS Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| COSCIENS Biopharma had very high historical volatility over the last 90 days | |
| COSCIENS Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 13.78 M. Net Loss for the year was (15.31 M) with profit before overhead, payroll, taxes, and interest of 4.42 M. | |
| COSCIENS Biopharma generates negative cash flow from operations | |
| COSCIENS Biopharma has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: United States Hair Care Products Market to Reach 38.27 Billion by 2033 Analysis of Trends, Investment Opportunities and Competition |
- Analyzing COSCIENS Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether COSCIENS Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining COSCIENS Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating COSCIENS Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of COSCIENS Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of COSCIENS Biopharma's stock. These opinions can provide insight into COSCIENS Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |